Sun.Jul 24, 2022

article thumbnail

Digital health investment undergoing a healthy reset, future to be defined by value

MedCity News

While 2022 will likely be a reset from the tremendous growth in digital health funding of 2021, this is a healthy correction and an opportunity to realign on core metrics.

129
129
article thumbnail

The Future of Pharmacy, The Ability to Move Beyond Dispensing for Pharmacists

Pharmacy Times

We need to be able to build on that momentum, and at the same time, we need sustainable reimbursement models.

49
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

iRhythm snags FDA approval for AFib characterization algorithm used in Verily’s wearable

MedCity News

Th FDA granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch. The clearance is for an algorithm that categorizes patients’ AFib by analyzing how much of it they experience over time.

FDA 121
article thumbnail

The Impact of Health Mart University for Communities, Pharmacies

Pharmacy Times

Health Mart was able to deliver the targeted education they needed in a virtual manner to allow them to start in the uniting and to keep their immunization credentials.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Health equity should start at birth

MedCity News

Pregnant women and others able to give birth are severely underrepresented in clinical research globally. But real-world data – when relevant, reliable, and fit for the purpose of answering a given research question – can be used to generate evidence on how health interventions perform in those who are pregnant.

Biopharma 108